FB News 71.29 07/24/2014 05:05:33 Facebook Inc (FB)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Facebook Inc (FB) 71.29 $FB

'Fast Money' Recap: Facebook and Analysts' Expectations
at The Street - 1 hr 5 mins ago
The trading panel discussed why they like Facebook's earnings and why they'd avoid Cheesecake Factory.

Why Facebook Will Soar Tomorrow and TripAdvisor Will Tumble
Jeremy Bowman, The Motley Fool - Motley Fool - Wed Jul 23, 9:00PM CDT
Stocks finished mixed today as a 2.6% gain in  Apple  stock following its earnings report last night led the  S&P 500  to a new closing record, gaining 0.2% to finish at 1,987, while the  Nasdaq  also moved up 0.4%. The  Dow Jones Industrial...

Facebook Shoots the Lights Out -- What's Not to Like About the Stock?
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Wed Jul 23, 6:35PM CDT
The march to 2,000 continues for the S&P 500! U.S. stocks finished higher on Wednesday, with the benchmark S&P 500 achieving a new record high off an 0.2% gain. Meanwhile, the narrower Dow Jones Industrial Average fell 0.2%, while the...

Why Facebook Is Even Scarier Than You Realize
at The Street - Wed Jul 23, 6:21PM CDT
The earnings were great, sure. But the real tell is the social network is now a data powerhouse and a branding platform


Get paid for posts? Social networking's new twist
By The Associated Press - AP - Wed Jul 23, 6:02PM CDT
SAN FRANCISCO (AP) — Facebook and most other social networks are built on the premise that just about everything should be shared —except the money those posts produce.

Will Facebook and Oculus VR Lead the Virtual Reality Revolution?
Keith Noonan, The Motley Fool - Motley Fool - Wed Jul 23, 6:00PM CDT
Source: OculusVR.com Facebook made waves back in March when it announced plans to purchase virtual reality pioneer Oculus VR. The $2 billion move shocked the tech world, as prior to the announcement, the small, privately owned Oculus looked to...

Twitter admits to diversity problem in workforce
The Associated Press - AP - Wed Jul 23, 5:34PM CDT
SAN FRANCISCO (AP) — Twitter acknowledged that it has been hiring too many white and Asian men to fill high-paying technology jobs, just like several other major companies in Silicon Valley.

Facebook 2Q earnings, revenue soar
By The Associated Press - AP - Wed Jul 23, 5:17PM CDT
MENLO PARK, Calif. (AP) — Facebook is on a roll. The world's largest online social network posted sharply higher earnings on Wednesday as revenue from mobile advertising continued to grow, and more people used it, more often.

Facebook Q2 Earnings Live Blog Recap
at The Street - Wed Jul 23, 5:08PM CDT
Facebook earnings blew past Wall Street estimates, as the social network continues to be a mobile advertising giant.

Most active Nasdaq-traded stocks
AP - Wed Jul 23, 5:02PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

Facebook (FB) Beats Q2 Earnings, Stock Soars Higher - Analyst Blog
Mark Vickery - Zacks Investment Research - Wed Jul 23, 4:38PM CDT
Facebook (FB) GAAP earnings per share (EPS) reached 30 cents on revenues of $2.9 billion in the quarter.

The S&P 500 Closes at Yet Another All-Time Closing High on No Volume
at The Street - Wed Jul 23, 4:34PM CDT
The stock indexes closed mixed on Wednesday with the S&P 500 setting a new all-time closing high.

Facebook Reports Earnings
Anders Bylund, The Motley Fool - Motley Fool - Wed Jul 23, 3:56PM CDT
Social network operator Facebook just reported results for the second quarter of fiscal year 2014. Facebook beat analyst estimates across the board, and share prices rose nearly 5% in after-hours trading. Wall Street firms were looking for ...

Why Facebook Shares Are Surging
at The Street - Wed Jul 23, 3:56PM CDT
Facebook shares surge in after-hours trading following better-than-expected quarterly results led by strong mobile advertising revenue growth.

Stock Market Today: Record Intraday Moves for S&P 500 on Apple, Pepsi Earnings
at The Street - Wed Jul 23, 3:19PM CDT
U.S. stocks close mixed Wednesday as investors digest earnings from some of the biggest market players including Apple, PepsiCo and Microsoft.

Why Facebook (FB) Stock Is Up in After-Hours Trading Today
at The Street - Wed Jul 23, 3:19PM CDT
Facebook (FB) is gaining after-hours Wednesday after beating analysts' estimates for earnings and revenue in the second quarter.

Facebook Reports Second Quarter 2014 Results
PR Newswire - Wed Jul 23, 3:05PM CDT
Facebook, Inc. (NASDAQ: FB) today reported financial results for the quarter ended June 30, 2014.

S&P 500 Flirts With High; Breadth Missing On Nasdaq
at Investor's Business Daily - Wed Jul 23, 2:14PM CDT
Stocks kept to a tight trading range Wednesday as the market headed into its final hour of action. The Nasdaq was up 0.4% and the S&P 500 0.2%, but the Dow Jones industrial average eased 0.1%. Volume was running above the previous session's pace on...

LinkedIn Corp Will Crush Facebook In This Ad Market
Evan Niu, CFA, The Motley Fool - Motley Fool - Wed Jul 23, 1:45PM CDT
Source: Bizo. On Tuesday, LinkedIn announced a hefty $175 million acquisition of Bizo, a leading company that specializes in business-to-business, or B2B, marketing. The deal consists of 90% cash and 10% stock, and is expected to close during...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading